Autophagy-Enhancers to Reduce Sleep Disturbances — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Autophagy-Enhancers to Reduce Sleep Disturbances — Stella

Home/Mild Cognitive Impairment Due to Alzheimer's Disease/

View on ClinicalTrials.gov

Recruiting

Back to Mild Cognitive Impairment Due to Alzheimer's Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Department of Neurology, University Medicine Greifswald, Greifswald, Mecklenburg-Vorpommern

Key details

Sponsor

University Medicine Greifswald

Collaborators

Department of Experimental Neuroimmunology, University Medicine, Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald

Enrollment target

~76 participants

Started

October 2025

Primary completion

December 2028

Age range

55 Years – 70 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.